000 02431 a2200769 4500
005 20250516165343.0
264 0 _c20130902
008 201309s 0 0 eng d
022 _a1538-3598
024 7 _a10.1001/jama.2013.109309
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOsinusi, Anuoluwapo
245 0 0 _aSofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial.
_h[electronic resource]
260 _bJAMA
_cAug 2013
300 _a804-11 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAntiviral Agents
_xadministration & dosage
650 0 4 _aBody Weight
650 0 4 _aFemale
650 0 4 _aHepacivirus
_xclassification
650 0 4 _aHepatitis C
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aInterferons
650 0 4 _aInterleukins
_xgenetics
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPrognosis
650 0 4 _aRibavirin
_xadministration & dosage
650 0 4 _aSofosbuvir
650 0 4 _aTreatment Outcome
650 0 4 _aUridine Monophosphate
_xadministration & dosage
650 0 4 _aViral Load
700 1 _aMeissner, Eric G
700 1 _aLee, Yu-Jin
700 1 _aBon, Dimitra
700 1 _aHeytens, Laura
700 1 _aNelson, Amy
700 1 _aSneller, Michael
700 1 _aKohli, Anita
700 1 _aBarrett, Lisa
700 1 _aProschan, Michael
700 1 _aHerrmann, Eva
700 1 _aShivakumar, Bhavana
700 1 _aGu, Wenjuan
700 1 _aKwan, Richard
700 1 _aTeferi, Geb
700 1 _aTalwani, Rohit
700 1 _aSilk, Rachel
700 1 _aKotb, Colleen
700 1 _aWroblewski, Susan
700 1 _aFishbein, Dawn
700 1 _aDewar, Robin
700 1 _aHighbarger, Helene
700 1 _aZhang, Xiao
700 1 _aKleiner, David
700 1 _aWood, Brad J
700 1 _aChavez, Jose
700 1 _aSymonds, William T
700 1 _aSubramanian, Mani
700 1 _aMcHutchison, John
700 1 _aPolis, Michael A
700 1 _aFauci, Anthony S
700 1 _aMasur, Henry
700 1 _aKottilil, Shyamasundaran
773 0 _tJAMA
_gvol. 310
_gno. 8
_gp. 804-11
856 4 0 _uhttps://doi.org/10.1001/jama.2013.109309
_zAvailable from publisher's website
999 _c23038391
_d23038391